Previous Article | Next Article ![]()
Journal of Virology, October 1998, p. 7978-7984, Vol. 72, No. 10
Departments of Molecular Biophysics and
Biochemistry, Pediatrics, and Epidemiology and Public Health, Yale
University School of Medicine, New Haven, Connecticut 06520
Received 6 April 1998/Accepted 26 June 1998
The transition of Epstein-Barr virus (EBV) from latency into the
lytic cycle is associated with the expression of two immediate-early viral genes, BZLF1 and BRLF1. Overexpression of ZEBRA, the product of BZLF1, is sufficient to disrupt latency in B lymphocytes and epithelial cells by stimulating expression of lytic cycle genes, including BRLF1. The BRLF1 product Rta functions as a transcriptional activator in both B lymphocytes and epithelial cells. However, Rta has
recently been reported to disrupt latency in an epithelial specific
manner (S. Zalani, E. Holley-Guthrie, and S. Kenney, Proc. Natl. Acad.
Sci. USA 93:9194-9199, 1996). Here we demonstrate that expression of
Rta is also sufficient for disruption of latency in a permissive B-cell
line. In HH514-16 cells, transfection of Rta leads to synthesis of
ZEBRA, viral DNA replication, and late gene expression.
However, Rta by itself is less potent than ZEBRA in the ability
to activate most early and late lytic cycle genes. In light of previous
work implicating ZEBRA in the activation of Rta, we suggest a
cooperative model for EBV entry into the lytic cycle. Expression of
either BZLF1 or BRLF1 triggers expression of the other immediate-early
factor, and together these activators act individually or in synergy on
downstream targets to activate the viral lytic cycle.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The Epstein-Barr Virus Rta Protein Activates Lytic
Cycle Genes and Can Disrupt Latency in B Lymphocytes
*
Corresponding author. Mailing address: Department of
Molecular Biophysics and Biochemistry, Yale University, 333 Cedar St., New Haven, CT 06510. Phone: (203) 785-4758. Fax: (203) 785-6961. E-mail: George_Miller{at}qm.yale.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|